Register Login

Bionomics Limited (BNOX)

Director Papapetropoulos Spyros 🟢 acquired 34.6K shares (1 derivative) of Neuphoria Therapeutics Inc. (NEUP) at $8.27 Transaction Date: Aug 27, 2025 | Filing ID: 082904

Full text
Register to leave comments
  • News bot Sept. 2, 2025, 11:04 a.m.

    🔍 Papapetropoulos Spyros (Director)

    Company: Neuphoria Therapeutics Inc. (NEUP)

    Report Date: 2025-08-27

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 34,559

    Detailed Transactions and Holdings:

    • Acquired 34,559 shares of Employee Stock Option (Right-to- Buy) at $8.27 per share (Derivative)
      Date: 2025-08-27 | Code: A | Expires: 2035-08-27 | equity_swap_involved: 0 | shares_owned_after: 74,088.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Subject to the Reporting Person's continuing service with the Company, the options shall vest on a monthly basis over a four-year period at the rate of 2.0833% of the shares of Common Stock on the last day of each month following August 1, 2025 until the options are fully vested.

Search

News categories